Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer.
Fizazi K, Beuzeboc P, Lumbroso J, Haddad V, Massard C, Gross-Goupil M, Di Palma M, Escudier B, Theodore C, Loriot Y, Tournay E, Bouzy J, Laplanche A. Fizazi K, et al. Among authors: massard c. J Clin Oncol. 2009 May 20;27(15):2429-35. doi: 10.1200/JCO.2008.18.9811. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364971 Clinical Trial.
Sequential therapy in renal cell carcinoma.
Escudier B, Goupil MG, Massard C, Fizazi K. Escudier B, et al. Among authors: massard c. Cancer. 2009 May 15;115(10 Suppl):2321-6. doi: 10.1002/cncr.24241. Cancer. 2009. PMID: 19402067 Free article. Review.
New agents in metastatic prostate cancer.
Fizazi K, Massard C. Fizazi K, et al. Among authors: massard c. Eur J Cancer. 2009 Sep;45 Suppl 1:379-80. doi: 10.1016/S0959-8049(09)70056-5. Eur J Cancer. 2009. PMID: 19775638 No abstract available.
[Prostate tumors].
Massard C, Fizazi K. Massard C, et al. Rev Prat. 2010 Jan 20;60(1):113-9. Rev Prat. 2010. PMID: 20222324 French. No abstract available.
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer.
Yu EY, Massard C, Gross ME, Carducci MA, Culine S, Hudes G, Posadas EM, Sternberg CN, Wilding G, Trudel GC, Paliwal P, Fizazi K. Yu EY, et al. Among authors: massard c. Urology. 2011 May;77(5):1166-71. doi: 10.1016/j.urology.2011.01.006. Urology. 2011. PMID: 21539969 Free PMC article. Clinical Trial.
476 results